跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 64,890 条关于
“Poly [ADP Ribose] Polymerase 1”
全部
64,890
临床试验
39,766
药物
8,087
机构
1,424
资讯
15,613
2年前
Endometrial Cancer Clinical Trial Landscape Shows Increasing Global Activity
2年前
Saruparib Shows Promise in HRR-Deficient Breast Cancer
去年
BRCA2 Mechanism Reveals Why PARP Inhibitors Work in Only Some Cancer Patients
9个月前
Zai Lab Secures Reimbursement Renewal for Three Key Therapies in China's 2025 National Drug List
5年前
Comparative Analysis of PARP Inhibitors in BRCA-Mutated Ovarian Cancer Shows Similar Efficacy and Toxicity
6年前
PARP Inhibitors Show Similar Efficacy in BRCA-Mutated Ovarian Cancer, Cost-Effectiveness Varies
12年前
Niraparib Maintenance Therapy Demonstrates Sustained Benefit in Recurrent Ovarian Cancer
4年前
PARP Inhibitors Show Promise in Ovarian Cancer Maintenance Therapy
11年前
PARP Inhibitors Show Promise in Epithelial Ovarian and Breast Cancers with BRCA1/2 Mutations
6年前
PARP Inhibitors in Frontline Ovarian Cancer Treatment: A Review of Clinical Trials
第 1 页，共 1562 页
上一页
下一页
